title: Stroke, mTBI, infection, antibiotics and beta blockade: Connecting the dots.
abstract: Several themes supported by a robust literature are addressed in this clinical translational review and research paper: (1) the inadequate standard of care for minimal traumatic brain injury (mTBI)/concussion when compared to stroke because diagnosis and care for mTBI/concussion are based primarily on a symptom only framework; (2) the treatment of stroke (brain injury) infection with select antibiotics; (3) the use of beta blockade in stroke (brain injury). The various etiologies of brain injury appear to coalesce to common endpoints: potential neuronal demise, cognitive and functional losses, immune suppression and infection. The use of principles patterned after 'Koch's Postulates' (show/prove the presence of infection/illness/disease, treat until resolved, and prove objectively that the disease/illness is gone/healed/cured) appears to be marginalized in establishing a diagnosis and recovery from mTBI/TBI. The pathways of immune system interactions in stroke (brain injury) and infection are briefly discussed. The suggestion of combined specific antibiotic and beta blockade for ischemic stroke (brain injury) and mTBI is advanced for treatment and expeditious further study. Stroke is considered a brain injury in this paper. Stroke is also considered and recommended as a study model for mTBI therapy because of their common end points from brain damage. It is suggested that potential transfer or translation of therapy for stroke may be useful in mTBI.
authors.affiliation: University of the Pacific, School of Pharmacy & Health Sciences, United States. Electronic address: k6md@aol.com.
authors.forename: Gerald Dieter
authors.initials: GD
authors.lastname: Griffin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001930:Brain Injuries / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007239:Infections / Q000276:immunology*; D018448:Models, Immunological; D020521:Stroke / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents